Barclays Upgrades Helmerich & Payne to Overweight

Barclays analyst David Anderson upgrades Helmerich & Payne (NYSE:HP) from Equal-Weight to Overweight.

byBenzinga Newsdesk

July 14, 2022

1 minute read

Barclays analyst David Anderson upgrades Helmerich & Payne (NYSE:HP) from Equal-Weight to Overweight.

JP Morgan Initiates Coverage On Kymera Therapeutics with Neutral Rating, Announces Price Target of $44

By Benzinga Newsdesk

Today, 5:19 AM

JP Morgan analyst Eric Joseph initiates coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Neutral rating and announces Price Target of $44.

KYMR

Nuvectis Pharma Announces Data For NXP900 In A Preclinical Model Of Group 4 Medulloblastoma, A Type Of Brain Cancer That Affects Predominantly Pediatric Patients

By Benzinga Newsdesk

Today, 5:19 AM

Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical

NVCT

News
Tech

Shanghai Government Reports Tesla Completes Production Capacity Expansion at Shanghai Plant

By Charles Gross

Today, 5:19 AM

-Reuters https://www.reuters.com/business/autos-transportation/tesla-completes-production-capacity-expansion-shanghai-plant-shanghai-govt-2022-09-19/

TSLA

News

Healixa Announces Major Milestone Towards Commercialization Of Its Global AquaDuct Product

By Benzinga Newsdesk

Today, 5:19 AM

Healixa, Inc. (OTC:EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and

EMOR

Barclays Upgrades Helmerich & Payne to Overweight

Related Posts

JP Morgan Initiates Coverage On Kymera Therapeutics with Neutral Rating, Announces Price Target of $44

Nuvectis Pharma Announces Data For NXP900 In A Preclinical Model Of Group 4 Medulloblastoma, A Type Of Brain Cancer That Affects Predominantly Pediatric Patients

Shanghai Government Reports Tesla Completes Production Capacity Expansion at Shanghai Plant

Healixa Announces Major Milestone Towards Commercialization Of Its Global AquaDuct Product